Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Nichi-Iko Pharmaceutical Co Ltd
Tax Provision
Nichi-Iko Pharmaceutical Co Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
Tax Provision
¥2.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Tax Provision
¥91.4B
|
CAGR 3-Years
110%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Tax Provision
-¥36.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Tax Provision
-¥21.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Tax Provision
-¥117.7B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-14%
|
|
Astellas Pharma Inc
TSE:4503
|
Tax Provision
-¥7.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
See Also
What is Nichi-Iko Pharmaceutical Co Ltd's Tax Provision?
Tax Provision
2.2B
JPY
Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Tax Provision amounts to 2.2B JPY.